Cargando…
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906471/ https://www.ncbi.nlm.nih.gov/pubmed/36622349 http://dx.doi.org/10.1182/bloodadvances.2022009475 |
| _version_ | 1784883987743768576 |
|---|---|
| author | Chang, Andres Koff, Jean L. Lai, Lilin Orellana-Noia, Victor M. Surati, Minal Leal, Alyssa M. K. Ellis, Madison L. Wali, Bushra Moreno, Alberto Linderman, Susanne L. O’Leary, Colin B. Allen, Pamela B. Churnetski, Michael C. Dhodapkar, Madhav V. Suthar, Mehul S. Cohen, Jonathon B. Ahmed, Rafi |
| author_facet | Chang, Andres Koff, Jean L. Lai, Lilin Orellana-Noia, Victor M. Surati, Minal Leal, Alyssa M. K. Ellis, Madison L. Wali, Bushra Moreno, Alberto Linderman, Susanne L. O’Leary, Colin B. Allen, Pamela B. Churnetski, Michael C. Dhodapkar, Madhav V. Suthar, Mehul S. Cohen, Jonathon B. Ahmed, Rafi |
| author_sort | Chang, Andres |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9906471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99064712023-02-08 Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies Chang, Andres Koff, Jean L. Lai, Lilin Orellana-Noia, Victor M. Surati, Minal Leal, Alyssa M. K. Ellis, Madison L. Wali, Bushra Moreno, Alberto Linderman, Susanne L. O’Leary, Colin B. Allen, Pamela B. Churnetski, Michael C. Dhodapkar, Madhav V. Suthar, Mehul S. Cohen, Jonathon B. Ahmed, Rafi Blood Adv Research Letter The American Society of Hematology 2023-01-10 /pmc/articles/PMC9906471/ /pubmed/36622349 http://dx.doi.org/10.1182/bloodadvances.2022009475 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Chang, Andres Koff, Jean L. Lai, Lilin Orellana-Noia, Victor M. Surati, Minal Leal, Alyssa M. K. Ellis, Madison L. Wali, Bushra Moreno, Alberto Linderman, Susanne L. O’Leary, Colin B. Allen, Pamela B. Churnetski, Michael C. Dhodapkar, Madhav V. Suthar, Mehul S. Cohen, Jonathon B. Ahmed, Rafi Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title_full | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title_fullStr | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title_full_unstemmed | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title_short | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies |
| title_sort | low neutralizing activity of azd7442 against current sars-cov-2 omicron variants in patients with b-cell malignancies |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906471/ https://www.ncbi.nlm.nih.gov/pubmed/36622349 http://dx.doi.org/10.1182/bloodadvances.2022009475 |
| work_keys_str_mv | AT changandres lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT koffjeanl lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT laililin lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT orellananoiavictorm lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT suratiminal lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT lealalyssamk lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT ellismadisonl lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT walibushra lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT morenoalberto lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT lindermansusannel lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT olearycolinb lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT allenpamelab lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT churnetskimichaelc lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT dhodapkarmadhavv lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT sutharmehuls lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT cohenjonathonb lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies AT ahmedrafi lowneutralizingactivityofazd7442againstcurrentsarscov2omicronvariantsinpatientswithbcellmalignancies |